Literature DB >> 3304959

Use of nitrates in acute and chronic congestive heart failure.

K Swedberg.   

Abstract

The literature available on the use of nitrates (glyceryl trinitrate, isosorbide dinitrate and isosorbide 5-mononitrate) as various formulations (oral, buccal, sublingual, transdermal and intravenous) in the treatment of acute and chronic congestive heart failure is reviewed. There are adequate data on the acute haemodynamic effects of these preparations, but little information is available on the long term use of nitrates in chronic congestive heart failure. The exception is isosorbide dinitrate, which, in combination with hydralazine, has been shown to reduce mortality.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3304959     DOI: 10.2165/00003495-198700334-00027

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  18 in total

1.  Effects of sublingual administration of nitroglycerin on pulmonary-artery pressure in patients with failure of the left ventricle.

Authors:  J B JOHNSON; J F GROSS; E HALE
Journal:  N Engl J Med       Date:  1957-12-05       Impact factor: 91.245

2.  Improved exercise capacity and differing arterial and venous tolerance during chronic isosorbide dinitrate therapy for congestive heart failure.

Authors:  C V Leier; P Huss; R D Magorien; D V Unverferth
Journal:  Circulation       Date:  1983-04       Impact factor: 29.690

Review 3.  Intravenous nitroglycerin. A review of pharmacology, indications, therapeutic effects and complications.

Authors:  N S Hill; E M Antman; L H Green; J S Alpert
Journal:  Chest       Date:  1981-01       Impact factor: 9.410

4.  Sustained hemodynamic effects without tolerance during long-term isosorbide dinitrate treatment of chronic left ventricular failure.

Authors:  J A Franciosa; J N Cohn
Journal:  Am J Cardiol       Date:  1980-03       Impact factor: 2.778

5.  [Comparative invasive examination of the effect of isosorbide-5-mononitrate and isosorbide dinitrate in chronic coronary insufficiency].

Authors:  K Bödigheimer; F G Nowak; W Delius
Journal:  Med Welt       Date:  1981-04-07

6.  Role of vasodilators in the treatment of congestive heart failure.

Authors:  T B Levine
Journal:  Am J Cardiol       Date:  1985-01-11       Impact factor: 2.778

7.  Acute and chronic effects of sustained action buccal nitroglycerin in severe congestive heart failure.

Authors:  A Lahiri; J C Crawley; T N Sonecha; E B Raftery
Journal:  Int J Cardiol       Date:  1984-01       Impact factor: 4.164

8.  Hemodynamic and hormonal response to transdermal nitroglycerin in normal subjects and in patients with congestive heart failure.

Authors:  M T Olivari; P F Carlyle; T B Levine; J N Cohn
Journal:  J Am Coll Cardiol       Date:  1983-11       Impact factor: 24.094

9.  Hemodynamic and hormonal effects of high-dose transdermal nitroglycerin in patients with chronic congestive heart failure.

Authors:  U Elkayam; A Roth; B Henriquez; L Weber; D Tonnemacher; S H Rahimtoola
Journal:  Am J Cardiol       Date:  1985-09-15       Impact factor: 2.778

10.  Hydralazine in the long-term treatment of chronic heart failure: lack of difference from placebo.

Authors:  J A Franciosa; K T Weber; T B Levine; G T Kinasewitz; J S Janicki; J West; M M Henis; J N Cohn
Journal:  Am Heart J       Date:  1982-09       Impact factor: 4.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.